We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
-$1.54M
Cap. Flow
+$1.94M
Cap. Flow %
1.28%
Top 10 Hldgs %
37.96%
Holding
86
New
25
Increased
15
Reduced
14
Closed
24

Top Buys

Rank Stock Value
1
ZSAN
Zosano Pharma Corporation
ZSAN
+$4.78M
2
SHPG
Shire pic
SHPG
+$3.44M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.29M
4
CNC icon
Centene
CNC
+$3.13M
5
LH icon
Labcorp
LH
+$2.99M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.83M
2
AERI
Aerie Pharmaceuticals
AERI
+$5.08M
3
ABBV icon
AbbVie
ABBV
+$4.84M
4
ESPR
Esperion Therapeutics
ESPR
+$4.77M
5
KTWO
K2M Group Holdings, Inc
KTWO
+$2.97M

Sector Composition

Rank Sector Weight
1 Healthcare 77.97%
2 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLVS
76
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-25,000
Closed -$1.7M
AERI
77
DELISTED
Aerie Pharmaceuticals
AERI
– –
-85,000
Closed -$5.08M
CCXI
78
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-100,000
Closed -$595K
XENT
79
DELISTED
Intersect ENT, Inc
XENT
– –
-75,000
Closed -$2.43M
WMGI
80
DELISTED
Wright Medical Group Inc
WMGI
– –
-20,000
Closed -$444K
AKCA
81
DELISTED
Akcea Therapeutics Inc
AKCA
– –
-100,000
Closed -$1.74M
AGN
82
DELISTED
Allergan plc
AGN
– –
-10,000
Closed -$1.64M
ABLX
83
DELISTED
Ablynx NV
ABLX
– –
-65,000
Closed -$1.62M
AVXS
84
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-15,000
Closed -$1.66M
JUNO
85
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-60,000
Closed -$2.74M
CELG
86
DELISTED
Celgene Corp
CELG
– –
-75,000
Closed -$7.83M
1 2 3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2018 Portfolio in Review

As of Q1 2018, Iguana Healthcare Management held 86 positions worth $152M, down 1% from $154M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Iguana Healthcare Management's Q1 2018 filing shows 25 new, 15 increased, 14 reduced and 24 closed positions. Its largest new stake was Zosano Pharma Corporation: 14,286 shares worth $2.52M. The largest sale was Celgene Corp, an estimated $7.83M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 82% a quarter earlier, followed by Energy.

  • Iguana Healthcare Management's largest Q1 2018 buy was Zosano Pharma Corporation: 14,286 shares worth $2.52M.
  • Iguana Healthcare Management added most to Arena Pharmaceuticals Inc in Q1 2018, an estimated $1.94M increase.
  • Iguana Healthcare Management's biggest Q1 2018 reduction was Esperion Therapeutics, cutting an estimated $4.77M.
  • Iguana Healthcare Management fully exited Celgene Corp in Q1 2018, selling an estimated $7.83M.
  • Iguana Healthcare Management's ten largest holdings make up 38% of its $152M portfolio in Q1 2018.
  • Iguana Healthcare Management opened 25 new positions and closed 24 in Q1 2018.
  • Iguana Healthcare Management's portfolio value fell 1% quarter-over-quarter to $152M.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.